A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

Clinical trial NCT06145893 · RECRUITING

Trial details

NCT number: NCT06145893
Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Behçet's Disease

Start date: 2023-11-13
Primary completion: 2026-05-30
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.